Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, September 1998, p. 2160-2170, Vol. 42, No. 9
Microbiology1 and
Measurement Science2 Departments,
Unilever Research, Colworth Laboratory, Sharnbrook, Bedford MK44
1LQ, United Kingdom
Received 25 February 1998/Returned for modification 9 April
1998/Accepted 29 May 1998
The inhibitory activity of a truncated derivative of the natural
amphibian skin peptide dermaseptin s3-(1-16)-NH2 [DS s3
(1-16)] against Saccharomyces cerevisiae was studied.
Significant growth inhibition was observed after exposure to
3.45 µg of the peptide per ml at pH 6.0 and 7.0, with complete growth
inhibition occurring at 8.63 µg of peptide per ml for all pH
values tested. Using confocal scanning laser microscopy, we have shown
that DS s3 (1-16) disrupted the yeast cell membrane resulting in the
gross permeabilization of the cell to the nuclear stain ethidium
bromide. However, the principal inhibitory action of the peptide was
not due to disruption of intracellular pH homeostasis. Instead, growth
inhibition by the peptide correlated with the efflux of important
cellular constituents such as ADP, ATP, RNA, and DNA into the
surrounding medium. The combination of DS s3 (1-16) with mild
heating temperatures as low as 35°C significantly enhanced the
inhibitory effect of the peptide (8.63 µg/ml), and at 45°C
greater than 99% of the population was killed in 10 min. In
summary, a derivative of a natural antimicrobial peptide has
potential, either alone or in combination with mild heating, to prevent
the growth of or kill spoilage yeast.
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Inhibitory Action of a Truncated Derivative of the Amphibian Skin
Peptide Dermaseptin s3 on Saccharomyces cerevisiae
*
Corresponding author. Mailing address: Microbiology
Department, Unilever Research, Colworth Laboratory, Sharnbrook, Bedford MK44 1LQ, United Kingdom. Phone: (44) 1234 222377. Fax: (44) 1234 222277. E-mail: peter.coote{at}unilever.com.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |